Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Amini

Showing results (171-180 of 181) with videos related to

Pageof 19
Sort By:
Nature Communications|August 18, 2021
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concernDonal T Skelly, Adam C Harding, Javier Gilbert-Jaramillo, et al.
Plos Pathogens|September 16, 2021
Identification of immune correlates of fatal outcomes in critically ill COVID-19 patientsJonathan Youngs, Nicholas M Provine, Nicholas Lim, et al.
Science Immunology|August 29, 2025
MAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccinesAli Amini, Lucy C Garner, Robert H Shaw, et al.
Cell|June 30, 2022
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serumAekkachai Tuekprakhon, Rungtiwa Nutalai, Aiste Dijokaite-Guraliuc, et al.
Cell|June 6, 2022
Potent cross-reactive antibodies following Omicron breakthrough in vaccineesRungtiwa Nutalai, Daming Zhou, Aekkachai Tuekprakhon, et al.
Cell Reports|December 31, 2022
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75Jiandong Huo, Aiste Dijokaite-Guraliuc, Chang Liu, et al.
Elife|August 22, 2020
Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational studyDavid W Eyre, Sheila F Lumley, Denise O'Donnell, et al.
Cell|November 4, 2021
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccineRebecca P Payne, Stephanie Longet, James A Austin, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responsesWanwisa Dejnirattisai, Jiandong Huo, Daming Zhou, et al.
Cell|January 26, 2022
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responsesWanwisa Dejnirattisai, Jiandong Huo, Daming Zhou, et al.
Pageof 19

Showing results (171-180 of 181) with videos related to

Sort By:
Pageof 19
Nature Communications|August 18, 2021
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concernDonal T Skelly, Adam C Harding, Javier Gilbert-Jaramillo, et al.
Plos Pathogens|September 16, 2021
Identification of immune correlates of fatal outcomes in critically ill COVID-19 patientsJonathan Youngs, Nicholas M Provine, Nicholas Lim, et al.
Science Immunology|August 29, 2025
MAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccinesAli Amini, Lucy C Garner, Robert H Shaw, et al.
Cell|June 30, 2022
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serumAekkachai Tuekprakhon, Rungtiwa Nutalai, Aiste Dijokaite-Guraliuc, et al.
Cell|June 6, 2022
Potent cross-reactive antibodies following Omicron breakthrough in vaccineesRungtiwa Nutalai, Daming Zhou, Aekkachai Tuekprakhon, et al.
Cell Reports|December 31, 2022
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75Jiandong Huo, Aiste Dijokaite-Guraliuc, Chang Liu, et al.
Elife|August 22, 2020
Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational studyDavid W Eyre, Sheila F Lumley, Denise O'Donnell, et al.
Cell|November 4, 2021
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccineRebecca P Payne, Stephanie Longet, James A Austin, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responsesWanwisa Dejnirattisai, Jiandong Huo, Daming Zhou, et al.
Cell|January 26, 2022
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responsesWanwisa Dejnirattisai, Jiandong Huo, Daming Zhou, et al.
Pageof 19